Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck’s “Beyond The Pill” Bet, Vree Health, Goes Commercial

Executive Summary

Vree Health, one of the independent subsidiaries Merck is fostering through its innovation ventures initiative, is moving into commercial phase, as it builds a business model that focuses on helping providers meet key goals of health care reform: higher quality and more cost-effective patient care.


Related Content

The End Of Drug Innovation In Diabetes?
Digital Health Is Changing Health Care. Is it Changing Pharma?
Biopharma In 2013: A Rising Tide
Medication Adherence: A Positive Story You Are Not Hearing
Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says
Next Up For Cubist: A Future That Includes Optimer, Trius
CMS Tinkers With Readmissions Policy, Other Quality Initiatives
Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts